Skip to main content

Table 1 Characteristics of patients with spontaneous intracerebral hemorrhage

From: The Osaka prognostic score and Naples prognostic score: novel biomarkers for predicting short-term outcomes after spontaneous intracerebral hemorrhage

Characteristics

Favorable outcome(n = 175, 0–2)

Poor outcome

(n = 114, 3–6)

P value

Age(years)

54.00

58.00

0.013c

Mean (SD)

(48.00–61.00)

(50.75-64.00)

Gender

 Male

120(68.6%)

75(65.6%)

0.622b

 Female

55(31.4%)

39(34.4%)

ICH score

 0(0–1)

152(86.9%)

64(56.1%)

< 0.001b

 1(2–4)

23(13.1%)

50(43.9%)

Cerebral hernia

2(1.1%)

10(8.8%)

0.004a

Hematoma expansion

10(5.7%)

14(12.3%)

0.048a

Intraventricular hemorrhage

49(28.0%)

45(39.5%)

0.042b

Surgery

22(12.6%)

47(41.2%)

< 0.001b

Complication

 infection

35(20.0%)

50(43.9%)

< 0.001b

 epilepsy

5(2.9%)

6(5.3%)

 deep vein thrombosis

7(4.0%)

6(5.3%)

 hydrocephalus

6(3.4%)

4(3.5%)

Hypertension

144(82.3%)

92(80.7%)

0.734b

Diabetes

18(10.3%)

11(9.6%)

0.860a

Cerebral infarction

6(3.4%)

6(5.3%)

0.445a

Cerebral hemorrhage

4(2.2%)

5(4.4%)

0.315a

Smoking

72(41.1%)

52(45.6%)

0.453b

Drinking

50(28.6%)

37(32.5%)

0.482b

Basic diseases

 cancer

25(14.3%)

10(8.8%)

0.310b

 lung diseases

24(13.7%)

8(7.0%)

 other diseases

6(3.4%)

6(5.3%)

GCS

15.00(13.00–15.00)

13.00(9.00–15.00)

< 0.001c

Hospital stays(day)

13.00(9.00–17.00)

17.5(13.75-25.00)

< 0.001d

Albumin(g/dL)

4.24(3.98–4.50)

4.21(3.91–4.45)

0.249c

Total cholesterol(mg/dL)

4.62(4.00-5.29)

4.52(3.85–5.06)

0.061c

C-reactive protein(mg/dL)

2.03(0.79–4.08)

2.14(0.85–7.39)

0.191c

Monocytes(10^9/L)

0.40(0.29–0.57)

0.45(0.31–0.70)

0.074c

Lymphocyte(10^9/L)

1.17(0.92–1.52)

1.00(0.72–1.36)

0.002c

Neutrophils(10^9/L)

6.81(5.03–9.03)

8.35(6.03–11.13)

0.001c

Hemoglobin(g/L)

142.00(133.00-154.00)

137.50(130.00-150.00)

0.085c

Platelet(10^9/L)

196.00(153.00-239.00)

192.50(145.75-239.25)

0.453c

COUNT

 1

56(32.0%)

26(22.8%)

0.019d

 2

109(62.3%)

75(65.8%)

 3

10(5.7%)

11(9.6%)

 4

0(0.0%)

2(1.8%)

SIS

 0

25(14.3%)

7(6.1%)

0.017d

 1

119(68.0%)

74(64.9%)

 2

31(17.7%)

33(29.0%)

PNI

 0

77(44.0%)

72(63.2%)

0.001d

 1

98(56.0%)

42(36.8%)

 

 LMR

2.97(2.05–4.22)

2.28(1.50–3.37)

< 0.001c

OPS

 0

0(0.0%)

0(0.0%)

< 0.001d

 1

53(30.3%)

26(22.8%)

 2

110(62.9%)

60(52.6%)

 3

12(6.8%)

28(34.4%)

NPS

 0

4(2.3%)

0(0.0%)

< 0.001d

 1

21(12%)

4(3.5%)

 2

76(43.4%)

35(30.7%)

 3

54(30.9%)

53(46.5%)

 4

20(11.4%)

22(19.3%)

  1. Abbreviations: GCS Glasgow coma scale, NLR Neutrophil-lymphocyte ratio, LMR Lymphocyte-monocyte ratio, OPS Osaka prognostic score, NPS Naples prognostic score
  2. aFisher’s exact test
  3. bχ2 test
  4. c t-test /U-test
  5. dRank sum test